FDA approves new treatment for moderately to severely active ulcerative colitis - FDA Press Releases

FDA today expanded the approval of Xeljanz (tofacitinib) to include adults with moderately to severely active ulcerative colitis.

from Food and Drug Administration--Press Releases https://ift.tt/2J1qP27
via IFTTT